Optic pathway glioma of childhood.
Rasool N, Odel JG, Kazim M.
Curr Opin Ophthalmol. 2017 May;28(3):289-295. doi: 10.1097/ICU.0000000000000370.
NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X, Yalçın B, Anastasaki C, Mulinyawe SB, Ponnuswami A, Scheaffer S, Ma Y, Chang KC, Xia X, Toonen JA, Lennon JJ, Gibson EM, Huguenard JR, Liau LM, Goldberg JL, Monje M, Gutmann DH.
Nature. 2021 Jun;594(7862):277-282. doi: 10.1038/s41586-021-03580-6. Epub 2021 May 26.
The Present and Future of Optic Pathway Glioma Therapy.
Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M.
Cells. 2023 Sep 29;12(19):2380. doi: 10.3390/cells12192380.
Optic nerve glioma: an update.
Nair AG, Pathak RS, Iyer VR, Gandhi RA.
Int Ophthalmol. 2014 Aug;34(4):999-1005. doi: 10.1007/s10792-014-9942-8. Epub 2014 Apr 16.
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Campagne O, Banerjee A, Gururangan S, Kilburn LB, Goldman S, Qaddoumi I, Baxter P, Vezina G, Bregman C, Patay Z, Jones JY, Stewart CF, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.
Neuro Oncol. 2021 Oct 1;23(10):1777-1788. doi: 10.1093/neuonc/noab047.
Current treatment of optic nerve gliomas.
Farazdaghi MK, Katowitz WR, Avery RA.
Curr Opin Ophthalmol. 2019 Sep;30(5):356-363. doi: 10.1097/ICU.0000000000000587.
NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.
Anastasaki C, Chatterjee J, Koleske JP, Gao Y, Bozeman SL, Kernan CM, Marco Y Marquez LI, Chen JK, Kelly CE, Blair CJ, Dietzen DJ, Kesterson RA, Gutmann DH.
Neuro Oncol. 2024 Aug 5;26(8):1496-1508. doi: 10.1093/neuonc/noae054.
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME, Gutmann DH.
J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28.
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y, Fan X.
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
[Clinical diagnosis and treatment of optic nerve glioma: a review].
Ren TT, Ma JM.
Zhonghua Yan Ke Za Zhi. 2023 May 11;59(5):415-419. doi: 10.3760/cma.j.cn112142-20221230-00664.
